Solara Active

{
  "main_header": {
    "sid": 1003017,
    "name": "Solara Active",
    "stock_name": "Solara Active",
    "full_name": "Solara Active Pharma Sciences Ltd",
    "name_url": "stocks-analysis/solara-active",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "502.15",
    "chg": -8.5,
    "chgp": "-1.66%",
    "dir": -1,
    "prev_price": "510.65",
    "mcapval": "2,443.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 541540,
    "symbol": "SOLARA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE624Z01016",
    "curr_date": "Aug 07, 03:30 PM",
    "curr_time": "02:47 AM",
    "last_traded_at": "Aug 07, 03:30 PM IST",
    "bse_nse_vol": "1.55 lacs",
    "exc_status": "Active",
    "traded_date": "Aug 07, 2026",
    "traded_date_str": "2026 08 07",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/solara-active-1003017-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Solara Active Pharma Sciences Ltd Faces Technical Downshift Amid Mixed Momentum Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/solara-active-pharma-sciences-ltd-faces-technical-downshift-amid-mixed-momentum-signals-4141051",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/SolaraActivePha_technicaldot_4141051.png",
        "date": "2026-08-07 08:05:45",
        "description": "Solara Active Pharma Sciences Ltd has experienced a notable shift in its technical momentum, transitioning from a sideways trend to a mildly bearish stance. This change is underscored by mixed signals from key technical indicators such as MACD, RSI, Bollinger Bands, and moving averages, reflecting a complex market sentiment for this small-cap pharmaceutical player."
      },
      {
        "title": "Solara Active Pharma Sciences Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/solara-active-pharma-sciences-ltd-is-rated-sell-4135099",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/SolaraActivePha_mojoScore_4135099.png",
        "date": "2026-08-04 10:10:22",
        "description": "Solara Active Pharma Sciences Ltd is rated Sell by MarketsMOJO. This rating was last updated on 03 August 2026. However, the analysis and financial metrics presented here reflect the stock’s current position as of 04 August 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Solara Active Pharma Sciences Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/solara-active-pharma-sciences-ltd-technical-momentum-shifts-amid-mixed-market-signals-4135282",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/SolaraActivePha_technicaldot_4135282.png",
        "date": "2026-08-04 08:09:46",
        "description": "Solara Active Pharma Sciences Ltd has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend, reflecting a complex interplay of indicator signals. Despite a modest day gain of 0.74%, the stock’s broader technical picture reveals cautionary signs, prompting a downgrade in its Mojo Grade from Hold to Sell as of 3 August 2026."
      },
      {
        "title": "Solara Active Pharma Falls 14.11%: 4 Key Factors Driving the Sharp Weekly Decline",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/solara-active-pharma-falls-1411-4-key-factors-driving-the-sharp-weekly-decline-4120472",
        "imagepath": "",
        "date": "2026-07-25 13:00:06",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>Jul 20:</strong> Stock opens at Rs.570.25, marginally down -0.11%</p>\n                    <p><strong>Jul 21:</strong> Technical momentum shifts to mildly bullish amid mixed signals</p>\n                    <p><strong>Jul 22:</strong> Intraday low hit at Rs.516.90 amid heavy price pressure</p>\n                    <p><strong>Jul 23:</strong> Q1 FY27 results show sharp profitability rebound</p>\n                    <p><strong>Jul 24:</strong> Reports very positive quarterly financial trend despite market weakness</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">R..."
      },
      {
        "title": "Are Solara Active Pharma Sciences Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-solara-active-pharma-sciences-ltd-latest-results-good-or-bad-4119796",
        "imagepath": "",
        "date": "2026-07-24 19:18:09",
        "description": "Solara Active Pharma Sciences Ltd's latest financial results for Q1 FY27 indicate a significant turnaround in profitability compared to previous quarters, where the company had faced losses. The net profit for the quarter stood at ₹16.31 crores, reflecting a substantial quarter-on-quarter growth of 69.90%. This marks a recovery from the previous quarter's profit of ₹9.60 crores. Additionally, the company reported net sales of ₹381.60 crores, which, while showing a slight sequential decline of 1.47% from ₹387.29 crores in Q4 FY26, demonstrates a robust year-on-year growth of 19.57%.\n\nThe operating margin, excluding other income, improved to 16.24%, up from 14.89% in the prior quarter, indicating better cost management and operational efficiency. The profit after tax (PAT) margin also expanded to 4.27%, up from 2.48% sequentially, although it remains below the levels typically expected in the pharmaceutical s..."
      },
      {
        "title": "Solara Active Pharma Sciences Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/solara-active-pharma-sciences-ltd-is-rated-hold-4119241",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/SolaraActivePha_mojoScore_4119241.png",
        "date": "2026-07-24 10:10:04",
        "description": "Solara Active Pharma Sciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 06 July 2026. While the rating was revised on that date, the analysis and financial metrics presented here reflect the stock's current position as of 24 July 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Solara Active Pharma Sciences Ltd Reports Very Positive Quarterly Financial Trend Amid Mixed Market Returns",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/solara-active-pharma-sciences-ltd-reports-very-positive-quarterly-financial-trend-amid-mixed-market-returns-4118435",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/SolaraActivePha_fintrenddot_4118435.png",
        "date": "2026-07-24 08:00:14",
        "description": "Solara Active Pharma Sciences Ltd has demonstrated a marked improvement in its financial performance for the quarter ended June 2026, shifting from a positive to a very positive trend. The company’s latest results reveal robust revenue growth, margin expansion, and record profitability metrics, signalling a turnaround in operational efficiency despite a challenging market environment and a recent decline in share price."
      },
      {
        "title": "Solara Active Pharma Q1 FY27: Profitability Rebounds Sharply Amid Margin Pressures",
        "link": "https://www.marketsmojo.com/news/result-analysis/solara-active-pharma-q1-fy27-profitability-rebounds-sharply-amid-margin-pressures-4118261",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/SolaraActivePha_quaterlyResult_4118261.png",
        "date": "2026-07-23 18:16:08",
        "description": "Solara Active Pharma Sciences Ltd. delivered a strong profitability rebound in Q1 FY27, with net profit surging 69.90% quarter-on-quarter to ₹16.31 crores, marking the company's highest quarterly profit in recent periods. The ₹2,560 crore market cap pharmaceutical company reported revenues of ₹381.60 crores for the June 2026 quarter, representing a modest 1.47% sequential decline but a robust 19.57% year-on-year growth. However, the stock remained under pressure, trading at ₹524.10 as of July 23, 2026, down 2.12% on the day and reflecting broader investor concerns about valuation and operational consistency."
      },
      {
        "title": "Solara Active Pharma Sciences Ltd Hits Intraday Low Amid Price Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/solara-active-pharma-sciences-ltd-hits-intraday-low-amid-price-pressure-4115158",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/SolaraActivePha_priceRelatedfactors_4115158.png",
        "date": "2026-07-22 10:21:37",
        "description": "Solara Active Pharma Sciences Ltd experienced a significant intraday decline on 22 Jul 2026, touching a low of Rs 516.9, reflecting a sharp price pressure of -7.42% during the trading session. The stock underperformed its sector and the broader market amid a continuation of recent downward momentum."
      }
    ],
    "total": 679,
    "sid": "1003017",
    "stock_news_url": "https://www.marketsmojo.com/news/solara-active-pharma-sciences-1003017"
  },
  "announcements": [
    {
      "caption": "Update With Respect To Our Intimation Dated July 23 2026 Regarding Appointment Of CIO And SMP Of The Company.",
      "datetime": "07-Aug-2026",
      "details": "Solara Active Pharma Sciences Limited has informed the exchange regarding the update with respect to our intimation dated July 23 2026 regarding appointment of Chief Information Officer (\"CIO\") and Senior Management Personnel (\"SMP\")",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
      "datetime": "29-Jul-2026",
      "details": "Transcript of Earnings Conference call pertaining to financial results of the Company for the quarter ended June 30 2026",
      "source": "BSE"
    },
    {
      "caption": "Submission Of Machine Readable Copy Of Financial Results For The Quarter Ended June 30 2026",
      "datetime": "24-Jul-2026",
      "details": "Solara Active Pharma Sciences Limited has informed the exchange regarding submission of Machine Readable copy of Financial results for the quarter ended June 30 2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Solara Active Pharma Sciences Ltd has declared <strong>30%</strong> dividend, ex-date: 18 Aug 21",
          "dt": "2021-08-18",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Solara Active Pharma Sciences Ltd has announced <strong>1:3</strong> rights issue, ex-date: 15 May 24",
          "dt": "2024-05-15",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Solara Active Pharma Sciences Ltd Faces Technical Downshift Amid Mixed Momentum Signals

2026-08-07 08:05:45

Solara Active Pharma Sciences Ltd has experienced a notable shift in its technical momentum, transitioning from a sideways trend to a mildly bearish stance. This change is underscored by mixed signals from key technical indicators such as MACD, RSI, Bollinger Bands, and moving averages, reflecting a complex market sentiment for this small-cap pharmaceutical player.

Read full news article

Solara Active Pharma Sciences Ltd is Rated Sell

2026-08-04 10:10:22

Solara Active Pharma Sciences Ltd is rated Sell by MarketsMOJO. This rating was last updated on 03 August 2026. However, the analysis and financial metrics presented here reflect the stock’s current position as of 04 August 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Solara Active Pharma Sciences Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-08-04 08:09:46

Solara Active Pharma Sciences Ltd has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend, reflecting a complex interplay of indicator signals. Despite a modest day gain of 0.74%, the stock’s broader technical picture reveals cautionary signs, prompting a downgrade in its Mojo Grade from Hold to Sell as of 3 August 2026.

Read full news article

Solara Active Pharma Falls 14.11%: 4 Key Factors Driving the Sharp Weekly Decline

2026-07-25 13:00:06

Key Events This Week

Jul 20: Stock opens at Rs.570.25, marginally down -0.11%

Jul 21: Technical momentum shifts to mildly bullish amid mixed signals

Jul 22: Intraday low hit at Rs.516.90 amid heavy price pressure

Jul 23: Q1 FY27 results show sharp profitability rebound

Jul 24: Reports very positive quarterly financial trend despite market weakness

Week Open

R...

Read full news article

Are Solara Active Pharma Sciences Ltd latest results good or bad?

2026-07-24 19:18:09

Solara Active Pharma Sciences Ltd's latest financial results for Q1 FY27 indicate a significant turnaround in profitability compared to previous quarters, where the company had faced losses. The net profit for the quarter stood at ₹16.31 crores, reflecting a substantial quarter-on-quarter growth of 69.90%. This marks a recovery from the previous quarter's profit of ₹9.60 crores. Additionally, the company reported net sales of ₹381.60 crores, which, while showing a slight sequential decline of 1.47% from ₹387.29 crores in Q4 FY26, demonstrates a robust year-on-year growth of 19.57%. The operating margin, excluding other income, improved to 16.24%, up from 14.89% in the prior quarter, indicating better cost management and operational efficiency. The profit after tax (PAT) margin also expanded to 4.27%, up from 2.48% sequentially, although it remains below the levels typically expected in the pharmaceutical s...

Read full news article

Solara Active Pharma Sciences Ltd is Rated Hold

2026-07-24 10:10:04

Solara Active Pharma Sciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 06 July 2026. While the rating was revised on that date, the analysis and financial metrics presented here reflect the stock's current position as of 24 July 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Solara Active Pharma Sciences Ltd Reports Very Positive Quarterly Financial Trend Amid Mixed Market Returns

2026-07-24 08:00:14

Solara Active Pharma Sciences Ltd has demonstrated a marked improvement in its financial performance for the quarter ended June 2026, shifting from a positive to a very positive trend. The company’s latest results reveal robust revenue growth, margin expansion, and record profitability metrics, signalling a turnaround in operational efficiency despite a challenging market environment and a recent decline in share price.

Read full news article

Solara Active Pharma Q1 FY27: Profitability Rebounds Sharply Amid Margin Pressures

2026-07-23 18:16:08

Solara Active Pharma Sciences Ltd. delivered a strong profitability rebound in Q1 FY27, with net profit surging 69.90% quarter-on-quarter to ₹16.31 crores, marking the company's highest quarterly profit in recent periods. The ₹2,560 crore market cap pharmaceutical company reported revenues of ₹381.60 crores for the June 2026 quarter, representing a modest 1.47% sequential decline but a robust 19.57% year-on-year growth. However, the stock remained under pressure, trading at ₹524.10 as of July 23, 2026, down 2.12% on the day and reflecting broader investor concerns about valuation and operational consistency.

Read full news article

Solara Active Pharma Sciences Ltd Hits Intraday Low Amid Price Pressure

2026-07-22 10:21:37

Solara Active Pharma Sciences Ltd experienced a significant intraday decline on 22 Jul 2026, touching a low of Rs 516.9, reflecting a sharp price pressure of -7.42% during the trading session. The stock underperformed its sector and the broader market amid a continuation of recent downward momentum.

Read full news article

View All News